Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 7.32%, which has investors questioning if this is right time to buy.

Novartis has announced a $23 billion investment over five years to expand US-based manufacturing and R&D, aiming to produce 100% of its key medicines domestically for American patients. The investment ...

Financing of Merida Biosciences was backed by Bain Capital Life Sciences, BVF Partners and Third Rock Ventures, with participation from multiple other investors. Merida Biosciences announced that it ...

At close: 9 April at 16:00:03 GMT-4 ...